Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;17(3):129-138.
doi: 10.1111/crj.13585. Epub 2023 Jan 29.

Aspergillus infection in chronic obstructive pulmonary diseases

Affiliations
Review

Aspergillus infection in chronic obstructive pulmonary diseases

Liang Guo et al. Clin Respir J. 2023 Mar.

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic airway non-specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients.

Keywords: chronic obstructive pulmonary disease (COPD); chronic pulmonary aspergillosis (CPA); invasive pulmonary aspergillosis (IPA).

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

FIGURE 1
FIGURE 1
Modified diagnostic procedure and treatment for IPA in COPD patients
FIGURE 2
FIGURE 2
Diagnostic procedures and treatment for CPA in COPD patients
FIGURE 3
FIGURE 3
Diagnostic procedures and treatment for aspergillus sensitisation in COPD patients

Similar articles

Cited by

References

    1. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121(6):1988‐1999. doi:10.1378/chest.121.6.1988 - DOI - PubMed
    1. Tudesq JJ, Peyrony O, Lemiale V, Azoulay E. Invasive pulmonary aspergillosis in nonimmunocompromised hosts. Semin Respir Crit Care Med. 2019;40(4):540‐547. doi:10.1055/s-0039-1696968 - DOI - PubMed
    1. Fréalle E, Reboux G, Le Rouzic O, et al. Impact of domestic mould exposure on aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease. Environ Res. 2021;195:110850. doi:10.1016/j.envres.2021.110850 - DOI - PubMed
    1. Alastruey‐Izquierdo A, Cadranel J, Flick H, et al. Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 2018;96(2):159‐170. doi:10.1159/000489474 - DOI - PubMed
    1. Bulpa P, Duplaquet F, Dimopoulos G, Vogelaers D, Blot S. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations. Semin Respir Crit Care Med. 2020;41(6):851‐861. doi:10.1055/s-0040-1702210 - DOI - PubMed

MeSH terms

Supplementary concepts